Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
98
-
Total 13F shares, excl. options
-
40M
-
Shares change
-
+1.01M
-
Total reported value, excl. options
-
$700M
-
Value change
-
+$18M
-
Number of buys
-
38
-
Number of sells
-
-48
-
Price
-
$17.48
Significant Holders of Replimune Group, Inc. - COMMON STOCK (REPL) as of Q2 2022
109 filings reported holding REPL - Replimune Group, Inc. - COMMON STOCK as of Q2 2022.
Replimune Group, Inc. - COMMON STOCK (REPL) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 40M shares
of 78.4M outstanding shares and own 51.04% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (5.88M shares), Omega Fund Management, LLC (4.67M shares), Redmile Group, LLC (3.65M shares), BAKER BROS. ADVISORS LP (3.59M shares), Atlas Venture Life Science Advisors, LLC (3.21M shares), BlackRock Inc. (2.32M shares), VANGUARD GROUP INC (1.76M shares), STATE STREET CORP (1.65M shares), EMERALD ADVISERS, LLC (1.09M shares), and FMR LLC (1.09M shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.